MASLD:

Wang-Hsin Lee1, Zachary A Kipp1, Evelyn A Bates1

  • 1Drug & Disease Discovery D3 Research Center, Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, U.S.A.

概括

肥胖是代谢功能障碍相关的脂肪性肝病 (MASLD) 和胰岛素抵抗的驱动因素. 本综述详细介绍了MASLD中脂肪和胰岛素抵抗的机制,并探索了治疗策略.